Manuel García Manero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manuel García Manero has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Begoña Olartecoechea
Department of Obstetrics and Gynecology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain
6 shared publications - Juan Luis Alcázar
Department of Obstetrics and Gynecology Hospital Quironsalud Málaga Spain
6 shared publications - Pedro Royo
Department of Obstetrics and Gynecology, Hospital San Jorge de Huesca, Avenida Martínez de Velasco, 22004 Huesca, Spain
5 shared publications G López
3 shared publicationsGemma Toledo
Department of Pathology, School of Medicine, University of Navarra, Pamplona, Spain
2 shared publicationsJuan Luis Alcazar
2 shared publications
Latest Publications
- 1 December 2010
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 153 (2) , 185-187
Different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience
- 1 December 2010
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 153 (2) , 185-187
Different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience
- 1 July 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (2) , 450-452
Interleukin-8 serum levels do not correlate with pelvic pain in patients with ovarian endometriomas
- 1 July 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (2) , 450-452
Interleukin-8 serum levels do not correlate with pelvic pain in patients with ovarian endometriomas
- 10 December 2009
- Vol. 53 (2) , 4-7
[Endometriosis].
Endometriosis is a common gynaecological disease of unknown aetiology which affects an estimated 10% to 15% of all premenopausal women. It is defined as the presence of endometrial tissue, consisting of both glandular epithelium and stroma, outside the uterine cavity. Three different clinical entities of endometriosis can be distinguished: peritoneal endometriosis, ovarian endometriosis and deep invasive endometriosis. There are several theories to explain their pathogenesis: metaplasia of the mesothelium, in situ development of Müllerian remnants in the rectovaginal area (deep-invasive lesions) or retrograde transplantation of shed menstrual effluent (peritoneal implants). The most widely accepted hypothesis for the development of endometriosis is retrograde menstruation. However, some other factor renders certain women susceptible to the implantation and growth of this ectopic endometrium.
- 10 December 2009
- Vol. 53 (2) , 4-7
[Endometriosis].
Endometriosis is a common gynaecological disease of unknown aetiology which affects an estimated 10% to 15% of all premenopausal women. It is defined as the presence of endometrial tissue, consisting of both glandular epithelium and stroma, outside the uterine cavity. Three different clinical entities of endometriosis can be distinguished: peritoneal endometriosis, ovarian endometriosis and deep invasive endometriosis. There are several theories to explain their pathogenesis: metaplasia of the mesothelium, in situ development of Müllerian remnants in the rectovaginal area (deep-invasive lesions) or retrograde transplantation of shed menstrual effluent (peritoneal implants). The most widely accepted hypothesis for the development of endometriosis is retrograde menstruation. However, some other factor renders certain women susceptible to the implantation and growth of this ectopic endometrium.
- 10 December 2009
- Vol. 53 (2) , 8-13
[Angiogenesis and endometriosis].
Endometriosis is a common gynaecological disease of unknown aetiology. Angiogenesis appears to be one of the processes involved in its pathogenesis. Angiogenic factors are increased in the peritoneal fluid of patients with endometriosis (McLaren 1996 et al; Taylor et al, 2002), in peritoneal implants (Ferriani et al, 1993) and in ovarian endometriomas. On the other hand, some researchers have found that angiogenesis is related to pelvic pain. We speculated that ovarian endometriomas in patients presenting with pelvic pain would be more angiogenic than those in asymptomatic women and that their vascular features would therefore be different.
- 10 December 2009
- Vol. 53 (2) , 8-13
[Angiogenesis and endometriosis].
Endometriosis is a common gynaecological disease of unknown aetiology. Angiogenesis appears to be one of the processes involved in its pathogenesis. Angiogenic factors are increased in the peritoneal fluid of patients with endometriosis (McLaren 1996 et al; Taylor et al, 2002), in peritoneal implants (Ferriani et al, 1993) and in ovarian endometriomas. On the other hand, some researchers have found that angiogenesis is related to pelvic pain. We speculated that ovarian endometriomas in patients presenting with pelvic pain would be more angiogenic than those in asymptomatic women and that their vascular features would therefore be different.
- 10 December 2009
- Vol. 53 (3) , 10-1
[Basic research into endometriosis. Are we going in the right direction?].
Endometriosis is a common gynaecological syndrome of unknown aetiology. The most widely accepted hypothesis for the development of endometriosis is retrograde menstruation. However, some other factor renders certain women susceptible to the implantation and growth of ectopic endometrium. Angiogenesis appears to be one of the process involved in the pathogenesis of endometriosis. Angiogenic factors are increased in the peritoneal fluid of patients with endometriosis in peritoneal implants and in ovarian endometriomas. We believe that the optimal serum marker should be used to monitor the response of new antiangiogenic agents in endometriosis treatment.
- 10 December 2009
- Vol. 53 (3) , 10-1
[Basic research into endometriosis. Are we going in the right direction?].
Endometriosis is a common gynaecological syndrome of unknown aetiology. The most widely accepted hypothesis for the development of endometriosis is retrograde menstruation. However, some other factor renders certain women susceptible to the implantation and growth of ectopic endometrium. Angiogenesis appears to be one of the process involved in the pathogenesis of endometriosis. Angiogenic factors are increased in the peritoneal fluid of patients with endometriosis in peritoneal implants and in ovarian endometriomas. We believe that the optimal serum marker should be used to monitor the response of new antiangiogenic agents in endometriosis treatment.
- 10 December 2009
- Vol. 53 (3) , 15-6
[Treatment to conserve fertility in a patient diagnosed with deep pelvic endometriosis].
- 10 December 2009
- Vol. 53 (3) , 15-6
[Treatment to conserve fertility in a patient diagnosed with deep pelvic endometriosis].
- Open Access
- 18 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 135
Endometriosis in a postmenopausal woman without previous hormonal therapy: a case report
The prevalence of pelvic endometriosis is high, affecting approximately 6% to 10% of women of reproductive age. Although endometriosis has been associated with the occurrence of menstrual cycles, it can affect between 2% to 5% of postmenopausal women.
- 18 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 135
Open AccessEndometriosis in a postmenopausal woman without previous hormonal therapy: a case report
The prevalence of pelvic endometriosis is high, affecting approximately 6% to 10% of women of reproductive age. Although endometriosis has been associated with the occurrence of menstrual cycles, it can affect between 2% to 5% of postmenopausal women.
- 1 February 2009
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 35 (2) , 215-218
Pregnancy associated breast cancer
- 1 February 2009
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 35 (2) , 215-218
Pregnancy associated breast cancer
- Open Access
- 30 January 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 42
Two-dimensional power Doppler-three-dimensional ultrasound imaging of a cesarean section dehiscence with utero-peritoneal fistula: a case report
An imaging diagnosis after an iterative cesarean delivery is reviewed demonstrating a fine ultrasound-pathologic correlation.
- 30 January 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 42
Open AccessTwo-dimensional power Doppler-three-dimensional ultrasound imaging of a cesarean section dehiscence with utero-peritoneal fistula: a case report
An imaging diagnosis after an iterative cesarean delivery is reviewed demonstrating a fine ultrasound-pathologic correlation.
- Open Access
- 1 January 2009
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 2 (1) , 18
Thrombospondin-1 serum levels do not correlate with pelvic pain in patients with ovarian endometriosis
Thrombospondin-1 serum levels is correlate with pelvic pain in patients with ovarian endometriosis. Thrombospondin-1 serum levels were prospectively analysed in 51 patients (group A asymptomatic patients or patients presenting mild dysmenorrhea and women comprised group B severe dysmenorrhea and/or chronic pelvic pain and/or dyspareunia) who underwent surgery for cystic ovarian endometriosis to asses whether a correlation exists among thrombospondin-1 serum levels and pelvic pain. From 56 patients, five cases were ultimately excluded, because the histological diagnosis was other than cystic ovarian endometriosis (2 teratomas and 3 haemorrhagic cysts). The mean thrombospondin-1 serum levels in group A was 256,69 pg/ml_+37,07 and in group B was 291,41 pg/ml + 35,59. Pain symptoms in ovarian endometriosis is not correlated with thrombospondin-1 serum levels.
- 1 January 2009
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 2 (1) , 18
Open AccessThrombospondin-1 serum levels do not correlate with pelvic pain in patients with ovarian endometriosis
Thrombospondin-1 serum levels is correlate with pelvic pain in patients with ovarian endometriosis. Thrombospondin-1 serum levels were prospectively analysed in 51 patients (group A asymptomatic patients or patients presenting mild dysmenorrhea and women comprised group B severe dysmenorrhea and/or chronic pelvic pain and/or dyspareunia) who underwent surgery for cystic ovarian endometriosis to asses whether a correlation exists among thrombospondin-1 serum levels and pelvic pain. From 56 patients, five cases were ultimately excluded, because the histological diagnosis was other than cystic ovarian endometriosis (2 teratomas and 3 haemorrhagic cysts). The mean thrombospondin-1 serum levels in group A was 256,69 pg/ml_+37,07 and in group B was 291,41 pg/ml + 35,59. Pain symptoms in ovarian endometriosis is not correlated with thrombospondin-1 serum levels.